Voyager Therapeutics, Inc.VYGRNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank75
3Y CAGR+9.0%
5Y CAGR+32.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+9.0%/yr
vs -41.7%/yr prior
5Y CAGR
+32.6%/yr
Recent deceleration
Acceleration
+50.6pp
Accelerating
Percentile
P75
Within normal range
vs 5Y Ago
4.1x
Strong expansion
Streak
2 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.00 | +33.6% |
| 2024 | 3.74 | +197.4% |
| 2023 | 1.26 | -67.5% |
| 2022 | 3.87 | +401.7% |
| 2021 | 0.77 | -36.8% |
| 2020 | 1.22 | -71.6% |
| 2019 | 4.30 | -87.1% |
| 2018 | 33.41 | -18.1% |
| 2017 | 40.79 | +103.0% |
| 2016 | 20.09 | - |